Arbutus Biopharma Corp (ABUS) Operating cash flow 2016–2025
Arbutus Biopharma Corp (ABUS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$39.6MFY2025 · since FY2016: -$57.9M → -$39.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.6M | +38.9% |
| FY2024 | -$64.8M | +24.5% |
| FY2023 | -$85.9M | -143.1% |
| FY2022 | -$35.4M | +47.6% |
| FY2021 | -$67.5M | -31.3% |
| FY2020 | -$51.4M | +27.6% |
| FY2019 | -$71.0M | -4.6% |
| FY2018 | -$67.9M | -39.5% |
| FY2017 | -$48.6M | +16.0% |
| FY2016 | -$57.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice